Dennis Matheis, Director at Lucid Diagnostics Inc. (LUCD), bought 666,782 shares at $1.32 ($873K) on 2025-05-21, disclosed to the SEC on 2025-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 187,098 | $243K | 27.9% |
| 2 | $1.30 | 187,098 | $243K | 27.9% |
| 3 | $1.32 | 129,684 | $171K | 19.6% |
| 4 | $1.32 | 129,684 | $171K | 19.6% |
| 5 | $1.32 | 33,218 | $44K | 5.0% |
| Total | $1.31 avg | 666,782 |
| $873K |
| 100% |
| Filing → |
| LUCD | BUY | 2025-08-22 | $102K | — | Filing → |